![BiomX Announces Agreement with Maruho Co., Ltd. for Atopic Dermatitis Product Candidate BX005](https://www.seventure.fr/wp-content/uploads/2020/07/10_104270789-322x211.jpg)
13 October 2021
BiomX Announces Agreement with Maruho Co., Ltd. for Atopic Dermatitis Product Candidate BX005
BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage cocktails that target...